An entry written while the outcome is still unknown. It will be scored by what the market does next, and it will never be edited to look cleverer than it was.
In plain words · Marriott International, Inc.
VERDICT
The label
Accumulation
read at $374.43
Marriott International holds its Accumulation at $374.43.
PHPhase · the trend structure carries the Accumulation label
INInsiders · no filings inside 60 days, left as found
POPositioning · no disclosures inside 60 days, left as found
OPOptions · no verdict drawn today, left as found
SCScreen · does not pass the values gate
edge confirmed
edge broken
edge forming
Each arm is one independent read. Conviction is not a single call, it is how many edges converge.
INVESTOR
The investor read · the season, not the day
As held on the ledger · 2026-07-24
Phase
Accumulation
Quantitative state
Consolidating, no directional conviction, held for 3 days
Price
$374.43
Valuation
39.21 trailing · 28.56 forward price to earnings
Values screen
FAIL· score 10.0
Beta
1.11
OPPORTUNITY
The opportunity · what the numbers say it is worth
Our framework reads AVOID — it trades above our $341.48 fair value estimate, 12.60% revenue growth.
Read at
$374.43
39.21 P/E · 28.56 fwd
Our fair value
$341.48
9% premium
Analyst target (avg)
$394.50
+5% to current
Target low $272.00Analyst target rangeTarget high $449.00
▲ current $374.43 · | average target
Price history & projections · where it has been, where the models see it going
The valuation journey · where the price sits against fair value and the Street
Current
$374.43
you are here
Conservative
$244.80
-35%
Analyst avg
$394.50
+5%
Our fair value
$341.48
-9%
Analyst high
$449.00
+20%
Green marks levels above today's price, red below; the shaded band is the gap between the price and our fair value.
Reading the gap · Our more conservative model reads it as fully-to-richly valued here, while the Street is more bullish — a quality-at-a-fair-price name rather than a deep-value one.
Revenue growth
12.60%
Profit margin
35.97%
Analyst consensus
Buy · 24 covering
Fair value and rating are our own model estimates; target range reflects third-party analyst estimates. Analysis, not advice.
SCREEN
The values screen, explained · five checks, plain English
It depends which standard you follow. There are two widely recognised ways to check whether a company is suitable for a Muslim investor, and on this company they disagree. Here is how it did on each:
The common standard· AAOIFI Used by most halal investing apps✓ PASSES
Our stricter standard· asset-based The one Titan applies✗ DOES NOT PASS
Why the two disagree. They fall out over one thing only: the company’s debt. Our stricter standard measures that debt against what the company owns, and it works out too high to pass. The common standard measures the same debt against what the company is worth on the stock market, where it works out low enough to pass. Every other check, the two agree on. So in practice, most halal apps would treat this as fine to hold, while our stricter view would not — and which line you follow is between you and your scholar.
Business activityIts core business isn't built on prohibited lines — no gambling, alcohol, tobacco, weapons, or interest-based lending.Pass
Debt loadInterest-bearing debt is 62.0% of its assets, above the one-third ceiling the screen allows. Against market value it is 17.6%, under the 30% line the market-value standard uses — so that standard clears it.Divergent
Interest-bearing cashCash held in interest-bearing accounts and securities is 1.1% of assets, under the one-third limit.Pass
ReceivablesMoney owed to the company is 11.9% of assets, under the 49% limit.Pass
Revenue purityOnly 0.2% of revenue comes from non-compliant sources — under the 5% line.Pass
Every security is read against two recognised standards: our stricter asset-based screen (ratios measured against total assets) and the more widely used market-value standard (measured against market capitalisation). Where they agree we say so plainly; where they part ways — almost always on the debt check — we show both readings and mark it, because that disagreement is the finding, not a fault. We report the score; you and your scholar make the call.
PLAIN
The business, in plain words · what the numbers mean
Luxury hotels mask heavy debt burden
Picture a packed hotel lobby where every room books out, yet the owner still owes the bank more than the building is worth. Marriott shows solid revenue growth of 13 percent and a 36 percent profit margin, yet the shares trade above our fair value at a forward multiple of 28 times. That combination, plus the ethical screen failure on debt levels, is why we pass.
The business operates across every major region and carries a buy rating from most analysts, yet the price leaves little margin for the cycles that hit lodging hardest. High debt ratios amplify any slowdown in travel or rise in interest costs.
Lodging remains cyclical by nature, so peak margins and stretched valuations often signal caution rather than opportunity. Analysis, not advice.
Screened names in the same industry · explore each on its own page.
TRADE
Where & how to trade · wherever in the world you are
MAR trades on a US exchange. As a US-listed security it is accessible through almost any international broker offering US markets. New to this, or investing from outside the US? Our guide to accessing global markets covers brokers, currencies and the practical steps.
TRADER
The trader read · the latest dated commentary
The framework reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 22% above its long-term trend line with momentum reading overbought. Over the past year the shares are up 45%. Our forward projection puts the odds of a 10% gain over the next month near 23%. The street (24 analysts) rates it buy, with a mean price target of $377. Entered 2026-07-18 · Accumulation
JOURNAL
The dated journal · newest first, never edited
2026-07-18Accumulation$392.51+0.0%Entry 3
The framework reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 22% above its long-term trend line with momentum reading overbought. Over the past year the shares are up 45%. Our forward projection puts the odds of a 10% gain over the next month near 23%. The street (24 analysts) rates it buy, with a mean price target of $377.
2026-07-03Accumulation$392.51+0.0%Entry 2
The framework reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns.
2026-07-02Accumulation$392.51Entry 1
The framework reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
INSIDERS
The insider ledger · Form 4 filings, as filed
Most recent filings · MAR
Date
Insider
Title
Type
Shares
Value
2026-05-18
ROE PEGGY FANG
Officer
3,000
$1,084,680
2026-05-13
MAO YIBING
Officer
4,816
$1,674,620
2026-05-11
HARRISON DEBORAH MARRIOTT
Director and Beneficial Owner of more than 10% of a Class of Security